Epilepsy and Cerebral Palsy by Mesraoua, Boulenouar et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter
Epilepsy and Cerebral Palsy
Boulenouar Mesraoua, Musab Ali, Dirk Deleu,
Hassan Al Hail, Gayane Melikyan, Naim Haddad,
Osama Alalamy, Covanis Athanasios and Ali A. Asadi-Pooya
Abstract
Abnormalities of muscle tone, movement, and motor skills are the hallmark of
cerebral palsy (CP) which results from injury to the developing brain. Clinically, the
syndrome evolves over time and may only be apparent after 3–5 years of age,
although suggestive signs and symptoms may be present at an earlier age. Epilepsy
is common in CP and occurs in about 30% of patients. Generally, the onset is within
the first 2 years of life. Epilepsy is commonly observed in children with spastic
hemiplegia, followed by quadriplegia and diplegia. Significant risk factors for the
development of epilepsy in patients with CP are family history, neonatal seizure,
structural abnormalities, low Apgar scores, and mental retardation. Focal to bilat-
eral tonic-clonic seizures are the most prominent seizure types, followed by focal
aware or impaired awareness seizures, while infantile spasms and myoclonic jerks
are seen in 25% of cases. Mental retardation is a predisposing factor for early onset
of seizures and more severe epilepsy. The overall outcome of seizures in children
with CP is generally poor, requiring prolonged course of antiepileptic medication,
usually polytherapy with higher incidence of refractory seizures, side effects,
comorbidities, and hospital admissions for drug-resistant seizures or status
epilepticus.
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1. Introduction
Cerebral palsy is a term that implies a disorder of motor function. It is a
neurodevelopmental abnormality affecting muscle tone, movement, and motor
skills. CP is the result of a nonprogressive damage of the nervous system at its early
developmental stage and can be caused by several factors encountered in prenatal,
perinatal, or postnatal periods [1]. Although the disorder itself is nonprogressive,
the clinical expression changes over time as the brain develops and matures.
The International Consensus in 2005 defined CP as follows [2]: “CP is a group of
permanent neurological disorders resulting from nonprogressive brain injury or
malformation that occurred in the developing fetal or infant brain and primarily
affecting body movement, posture and muscle coordination. The motor dysfunc-
tion in CP is often associated with abnormal cognitive abilities including communi-
cation and behavior, disturbance in sensation and perception and last but not least,
epilepsy and secondary musculoskeletal complications”.
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There is no consensus in the literature about the prevalence of epilepsy in
patients with CP. Studies indicate a very wide range of epilepsy in children with CP.
However, it is argued that in certain types of CP, higher rate of epilepsy is found
and that an average of 30% of patients with CP exhibit seizures. This figure is
proportional to the degree of motor and cognitive disabilities [3, 4].
2. Prevalence and incidence of cerebral palsy
The estimated prevalence of CP is approximately 2 per 1000 children. The risk is
even higher in preterm infants with low birth weight [5, 6].
The advances in prenatal, perinatal, and postnatal pediatric care significantly
influenced the reported incidence and prevalence of CP. The most common causes of
CP have varied over time and between geographical locations. While the developed
world faces predominantly prematurity and extremely low-birth-weight-related
morbidities, the developing countries are still faced with prenatal rubella, perinatal
asphyxia, and postnatal hyperbilirubinemia.
From the 1960s to 1980s, the rate of CP and the extent of disability among
preterm infants increased as survival improved for the most immature [7]. This
trend reversed later, most likely because of improvements in perinatal care [8].
3. Etiology of cerebral palsy
The etiology of CP is multifactorial. Most cases are likely related to prenatal
factors: among them prematurity and/or low birth weight. Other associated etiolo-
gies include congenital abnormalities, multiple pregnancy, placental pathology,
intrauterine infection, metabolic encephalopathies, and genetic forms of CP.
Perinatal hypoxia and ischemia account for only a marginal number of cases of
CP. Stroke in the perinatal period may cause CP and is typically manifested as
spastic hemiparesis.
In an Australian study of 213 children diagnosed with CP [9], a multifactorial
etiology was demonstrated. Major CP-associated pathologies, other than acute
intrapartum hypoxia, were found in 98% of cases; some children had several asso-
ciated pathologies such as
• Prematurity (78%).
• Intrauterine growth restriction (34%).
• Intrauterine infection (28%).
• Antepartum hemorrhage (27%).
• Severe placental pathology (21%).
• Multiple pregnancy (20%).
• Very-low-birth-weight (VLBW) infants (5–15%). In these cases, CP is
frequently associated with periventricular leukomalacia, intraventricular
hemorrhage, and/or bronchopulmonary dysplasia.
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4. Clinical features and classification of cerebral palsy
The classification of CP is based on the type and distribution of motor
abnormalities. Suggestive signs and symptoms may be present in infancy, and
severe cerebral palsy can be diagnosed as early as 1 month of age. However,
the specific CP syndromes are best recognized in time as the child’s brain
matures, e.g., spastic CP is usually diagnosed after the age of 6 months, dyski-
netic CP usually after 18–20 months old, and the ataxic type even later.
Following-up the children with high risk will allow early recognition and
intervention.
Early diagnosis, in some cases, will enable early intervention for the child by a
multidisciplinary team and in addition early psychological and possible financial
support to the family.
Early signs of CP include as follows:
Neurobehavioral findings: a neonate who presents with poor feeding with or
without recurrent vomiting, irritability, poor sleeping pattern, and poor visual
attention should raise suspicion of CP. In addition, prolonged retention or
exaggeration of these primitive reflexes is often a premature sign of motor
disability. In infants with hyperactive tonic labyrinthine reflex, opisthotonus
may occur, or they may roll over at an earlier age than usually expected.
Similarly, children with CP may present inadequate posture in vertical suspension
in that they present persistent extension of lower extremities on attempting a sitting
position.
Motor tone and posture: Tone can be normal in some subjects, but it may be
increased or decreased in the extremities of others.
Delay in sitting without support beyond 9 months, poor head control, persistent
or asymmetric hand fisting beyond 4 months, and abnormal oromotor patterns
(tongue thrusting or grimacing) are often the early motor signs. Sometimes
increased neck extensor and axial tone may make head control appears better than
it is.
The abovementioned features may also coincide with intellectual impairment,
hemianopia, and other visual problems. Also, behavioral problems are
frequently found among children with hemiplegic CP including anxiety and specific
phobias.
After age 18–24 months, signs and symptoms generally align to a specific
subtype of CP:
Spastic CP includes spastic diplegia, spastic hemiplegia, and spastic
quadriplegia, with accompanying features pointing to an upper motor neuron
syndrome like spastic hypertonia, hyperreflexia, extensor plantar responses, and
Dyskinetic CP is characterized by involuntary, stereotyped, uncontrolled, recurring
movements of athetosis, chorea, and dystonia.
CP associated with ataxic movements (loss of orderly muscular coordination,
unstable gait) and speech is referred to as ataxic CP and is usually associated
with a widespread disorder of motor function. Ataxic CP is rare, and children
who present with these findings must be evaluated for other potential causes
of ataxia.
Mixed CP is a spastic type with ataxic and/or dyskinetic features of variable
predominance.
Hypotonic CP is not included in the contemporary classifications. Majority of
patients with “hypotonic CP” in early infancy later develop spastic, dyskinetic,
or ataxic CP. Table 1 shows the proportion of the different types of CP.
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5. Associated comorbidities
Besides motor disabilities, there are significant comorbid disorders of cerebral
function that may appear or become severe as the child grows including intellectual
disability, seizures, behavioral and emotional disorders, speech and language disor-
ders, as well as visual and hearing impairments. Social difficulties and autism
spectrum disorders are also commonly associated comorbidities [10]. In addition,
many accompanying conditions such as growth failure, pulmonary disease, ortho-
pedic problems (e.g., joint subluxations and dislocations and hip dysplasia),
osteopenia, urinary disorders, sleep disturbance, and hypersalivation have been
identified. Pain is common in children with CP and can significantly impact the
quality of life. Children with more severe motor disabilities are also more likely to
have comorbidities.
These associated comorbidities occur in CP at variable rates. Pain is noted in 75%
of CP subjects, intellectual disability in half of them, whereas inability to walk or
hip displacement is equally seen in a third. Twenty-five percent of children with CP
cannot talk, and a similar proportion carries a diagnosis of epilepsy. Behavioral
disorders and urinary incontinence are equally seen in roughly 25% of subjects and
sleep disorders in 20%; tube feeding is needed in little less than 10%. Blindness is
noted in 10% of cases, with deafness being less common at a rate of 5%.
6. Neuroimaging in cerebral palsy
Head CT scan commonly identifies abnormalities, particularly in spastic CP.
Cerebral atrophy is a frequent finding in quadriplegia, whereas infarction,
porencephalic cyst, and cerebral atrophy occur equally (26.7%) in hemiplegic CP,
and periventricular leukomalacia is significantly more common with diplegia. A
brain abnormality seen on CT scan has been reported in 77% of the cases of hemi-
plegia, followed by quadriplegia (75%) and diplegia (55%) [11], while other studies
showed CT abnormalities in 77.2% of patients, with bilateral atrophy in 42.1% and
focal findings in 17.6% of the cases [12].
MRI scan is an important and safe diagnostic tool to use in children with CP after
18 months in order to assess location, nature, and structure of brain lesion and
correlate findings with clinical picture.
The patterns of MRI in children with cerebral palsy are as follows:
• White matter damage, observed more often in spastic diplegia and
quadriplegia.
Spastic subtypes Percentages (%)
Spastic diplegia 13–25
Spastic hemiplegia 21–40
Spastic quadriplegia 20–43
Dyskinetic subtypes 12–14
Ataxic CP 4–13
Table 1.
Proportion of the different types of cerebral palsy.
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• Gray matter damage: central gray matter damage of acute perinatal hypoxia-
ischemia in term infants is associated with death and CP.
• Enlarged ventricles, bilateral or unilateral, abnormalities of the atria and
ventricular or occipital horns, and posterior fossa, atrophy, and cerebrospinal
fluid abnormalities [13].
In a European cerebral palsy study [14], MRI was performed in 351 of the 431
children with clinically assessed CP. The MRI scans showed that white matter damage
of immaturity, including periventricular leukomalacia, was the most common finding
(42.5%, majority born before 34 weeks), followed by basal ganglia lesions (12.8%),
cortical/subcortical lesions (9.4%), malformations (9.1%), focal infarcts (7.4%), and
miscellaneous lesions (7.1%). Normal MRI findings were present in 11.7%.
MRI scan does provide useful information on the timing and extent of the lesion.
Predisposing risk factors include maternal and child genetic factors in
thrombophilia leading to stroke, nutritional factors, and infections during
Figure 1.
Salient MRI changes in cerebral palsy. Panel A shows a T2-weighted image with periventricular
hyperintensities and undulating ventricular margins (solid arrow). This is typically seen in prematurity
associated insult and commonly manifests as spastic diplegia. Panel B shows multicystic encephalomalacia
(dotted line with arrow). This pattern of watershed lesions is seen commonly in term infants with ischemia/
asphyxia and manifests clinically with spastic quadriplegia. Panel C illustrates T2 hyperintensities in posterior
putamen (open arrow) and thalami bilaterally (dotted line with closed arrow). This is typically seen in infants
with term hypoxic ischemic encephalopathy (HIE) and manifests as dyskinetic cerebral palsy. Panel D
highlights T2 hyperintensities in occipital lobe (solid arrow); characteristic of neonatal hypoglycemic insult.
Panel E shows T2 hyperintensity involving bilateral globuspallidi (open arrow), a feature of kernicterus
sequelae.
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pregnancy and before the onset of premature labor lead to placental damage devel-
oping throughout the pregnancy. These factors predispose the infant to an increased
risk of hypoxic ischemic episodes, leading to white matter damage.
It is not unreasonable, therefore, to assume that with increased awareness of
possible preventive measures, CP could be reduced substantially, reducing as a
consequence the burden on families and saving tremendous sums of money for
health services. Figure 1 shows the MRI findings in CP.
7. Evaluation of patient with cerebral palsy
The diagnostic evaluation must include standardized assessment of neurologic
and motor development and magnetic resonance imaging (MRI).
Screening for thrombophilia is recommended in children with MRI evidence of
cerebral infarction.
Other testing depends on clinical and anamnestic concerns and may include:
• Metabolic and genetic testing, which should be pursued in the presence of
atypical symptoms or MRI findings (e.g., a brain malformation or injury) or if
no etiology is identified by clinical history and neuroimaging
• Electroencephalogram (EEG) if seizure activity is suspected
• Infectious work-up (TORCH titers) if pre- or perinatal history is suggestive
All children with CP need to be screened for commonly associated conditions,
such as intellectual disability, ophthalmologic abnormalities, hearing impairment,
speech and language disorders, and growth failure.
8. Diagnosis of cerebral palsy
A combination of clinical findings supports the diagnosis of CP; a single clinical
finding is generally not sufficient to establish the diagnosis.
Key features in the diagnosis of CP include:
1. Abnormal motor development and posture.
2. Brain injury is permanent and nonprogressive.
3.Motor impairment is attributed to an insult that occurred in the developing
fetal or infant brain.
4.Motor impairment results in limitations in functional abilities and activities.
5.Motor impairment is often accompanied by secondary musculoskeletal
problems, epilepsy, and/or disturbances of sensation, perception, cognition,
communication, and behavior.
9. Prognosis of cerebral palsy
Survival to adulthood is currently a standard for most children. An analysis of
children with CP born in different geographical areas of the United Kingdom
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between 1980 and 1996 revealed a 20-year survival in 87–94% of cases [15]. The
multivariate analysis revealed that survival was related to severity of impairment,
birth weight, and socioeconomic status, with the number of severe impairments
having the greatest effect.
Those children who do not achieve head balance by 20 months retain primitive
reflexes, have no postural reactions by 24 months, or do not crawl by approximately
5 years of age have generally poor prognosis for walking. Generally, all children
with hemiplegic CP and many with athetosis or ataxia will walk. Those who walk
independently do so around the age of 3; those who walk only with support may
take up to 9 years. Those who do not walk by 9 years of age are unlikely to ever
walk, even with support [16].
Functional outcome in CP also depends on other non-motor factors. These
include intelligence, physical function, ability to communicate, and personality
attributes.
10. Seizures in cerebral palsy patients
Besides the motor dysfunction, epilepsy is another important problem in chil-
dren with CP. It is sometimes more disabling than the motor disorder itself.
10.1 Incidence of seizures and epilepsy in CP
Epilepsy is highly correlated with CP.
The incidence of epilepsy in CP varies from 33 to 41% [11, 12]. The incidence
and type of epilepsy vary according to the type of CP.
The large variation in percentages reported in the literature can be explained in
part by the variable length of follow-up periods and the different average age of
studied subjects.
Reported rates of seizures and epilepsy in CP vary significantly depending on
the underlying pathology and etiology. Epilepsy occurs in 50–94% of children
with CP due to diffuse cortical malformations and injuries [17, 18] and in 50%
of children with CP secondary to suspected perinatal arterial ischemic stroke
[19, 20]. Epilepsy occurs at a much lower frequency (26–43%) in CP and white
matter injury (WMI) than in other etiologies [21–24]. The lower frequency of
epilepsy and WMI is related to the lack of involvement of cortical gray matter. A
recent publication [25] indicated that 25% of children with CP and WMI had
seizures beyond the neonatal period with electroclinical features of the age-
limited, epileptic syndromes of childhood, with favorable outcome in the major-
ity. Very interesting findings that need to be confirmed, guiding toward better
diagnostic, treatment, prognostic, and genetic issues at this early age group.
Seizure onset often occurs in the first 2 years of life. Sixty-one percent of
patients with CP had their seizure onset that early. Some reports indicate 36.7%
[12] to 69.7% [23] of patients with seizure onset in the first year of life. The onset
of epilepsy probably reflects the time of occurrence of brain damage and its
severity.
The age of seizure onset also depends on the type of CP. Over 60% of the
children with quadriplegia and diplegia have seizures in their first year of life, while
60% of the children with hemiplegia had their first seizure at a later age. Children
with myoclonic seizures and infantile spasms had seizure onset very early in
life [11].
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10.2 Risk factors for seizures in patients with CP
Family history, structural abnormalities (primarily brain atrophy and gray mat-
ter involvement), neonatal seizure, low Apgar scores, and mental retardation are
significant risk factors for the development of epilepsy in patients with CP.
CP patients with spastic quadriplegia or acquired hemiplegia are more prone to
seizures, whereas seizures are less common in mild symmetric spastic diplegia and
CP that is mainly athetoid.
The mode of delivery, the relative birth weight, head circumferences, and the
presence of consanguinity are not known to be risk factors for epilepsy in these
patients.
Risk factors for the development of epilepsy are shown in Table 2.
In a study of 452 patients with CP and 160 patients with both CP and epilepsy
[11], the incidence of epilepsy among patients with hemiparetic CP was 65.9%,
compared to 42.6% in patients with quadriparetic CP and 15.8% in patients with
paraparetic CP. The different levels and degrees of brain damage may account for
the various percentages.
Other studies revealed that epilepsy was found in 54% of quadriparetic, 34–60%
of hemiparetic, 27% of diparetic, and 23–26% of dystonic CP patients [26, 27].
The age at onset of seizures might differ depending on the type of CP. Carlsson
et al. reported the seizure onset of age as 6 months in quadriparetic CP, 12 months
in diparetic CP, and 2.5 years in hemiparetic CP [21].
10.2.1 Neonatal seizures
Neonatal seizures represent a strong predictor for the development of epilepsy.
A strong association of neonatal seizures with epilepsy was reported in the Collab-
orative Perinatal Project (NCPP) of the NIH summarizing 54,000 singleton preg-
nancies between 1959 and 1966 [28]. Subsequently, additional retrospective studies
provided clear evidence that in children with CP neonatal seizures were strongly
predictive for future development of epilepsy [11, 29].
Neonatal seizure history in patients with CP is a risk factor for epilepsy devel-
opment. In addition, the outcome for seizure control was negatively affected by this
history, and patients with neonatal seizure history are 3.3 times more likely to have
poor epilepsy prognosis than those who had no neonatal seizure history [30].
Table 2.
Type of CP as a risk factor for seizures.
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Hence, neonatal seizure history in CP is a significant risk factor for both epilepsy
development and poor epilepsy prognosis.
10.2.2 Family history of epilepsy
Family history of epilepsy is associated with a 5.5 times higher risk of epilepsy in
patients with CP [31].
10.2.3 Mental retardation
Mental retardation is more frequently observed in CP patients with seizures than
in those without seizures, and severe mental retardation is more likely in those with
multiple seizure types.
In patients with CP and mental retardation, the diagnosis of epilepsy presents
unique challenges. Generally, patients are unable to describe the epileptic events
themselves, parents may not recognize subtle seizure manifestations, and persons
trained in epilepsy witness the events only rarely.
Mental retardation is frequently observed in patients with both CP and epilepsy
compared to patients with CP only. In addition, the risk of epilepsy development is
higher in patients with CP who have mental retardation [32, 33].
Patients with CP and epilepsy have lower intelligence levels compared with CP
alone; the patients with paroxysmal abnormalities in the EEG had lower intelligence
levels and learning disabilities [34].
Mental retardation is most common in quadriplegic CP, followed by hemiplegic
CP. On the contrary, almost half of diplegic CP and 60% of children with dystonic
CP have normal to borderline intelligence, which again correlates well with the type
and location of brain damage. Mental retardation is associated with earlier age of
onset, increased frequency, and treatment-resistant seizures [11]. This might rep-
resent an underlying severity of brain injury that is responsible for the severity of
both cognitive deficit and epilepsy.
10.2.4 Apgar score and risk of seizures in CP patients
The risk of epilepsy is inversely proportional to the Apgar scores of term babies,
both at 5 and 10 minutes. This is significant even with relatively minor reductions in
these scores [35].
Low Apgar scores were also recognized as risk factors for epilepsy in the general
population in some other studies [36, 37].
No relationship has been found between the risk of epilepsy development and
gestational age [31]. In a study where 173 patients were categorized according to
their birth weight as appropriate for gestational age (76.9%), small for gestational
age (12.1%), and large for gestational age (11%), they found no correlation between
birth weight and risk of epilepsy development [38].
However, other studies reveal that low birth weight and prematurity increase
the risk of epilepsy development in patients with CP [12, 37, 39]. These studies
assessed Apgar scores and determined that premature babies have lower Apgar
scores; they suggested that the increased risk of epilepsy development among pre-
mature babies was actually related to low Apgar scores.
10.3 Types of seizures
All types of epileptic seizures can be seen in patients with CP. Focal impaired
awareness (complex partial) and focal to generalized tonic-clonic are the most
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frequent seizure types. Some syndromes, such as infantile spasms, West, and
Lennox-Gastaut syndromes, are particularly frequent.
Generalized epilepsy is the predominant form of epilepsy in CP. Generalized
seizures have been reported in 36.8%, followed by focal (partial) seizures in 33%,
West syndrome in 15.6%, and myoclonic jerks in 10.6%. Absence seizures are
usually of the atypical type reported in 3.3–6.7% [3].
In another study of patients with both CP and epilepsy, the following seizure
types were observed: 44.6% experience focal to generalized tonic-clonic, 41.1%
Figure 2.
Epileptic syndromes in 41 children with cerebral palsy.
Table 3.
Types of seizures in subtypes of CP [11].
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focal impaired awareness (complex partial), 7.1% focal aware (simple partial), 5.4%
myoclonic, and 1.8% experience atonic seizures [30]. This finding is in line with the
literature review [31]. Figure 2 and Table 3 show epileptic syndromes and types of
seizures in subtypes of CP in children with cerebral palsy.
10.4 Electroencephalogram (EEG)
EEG is essential in the work-up of children with CP and suspected seizures. It
can lend support to the diagnosis of epilepsy and assist in seizure/epilepsy classifi-
cation to better guide the choice of antiseizure drugs. However, there is no clinical
value of performing EEG testing in children with no suggestion of seizure activity
by history, and EEG testing is not useful in establishing the cause of CP.
The rate of EEG abnormalities observed in patients with CP and epilepsy is in
the range of 66–92.6% [4, 11, 31].
All of the subgroups of spastic CP had a greater than 70% incidence of abnormal
EEGs. Whereas in quadriplegic and diplegic CP, the EEG shows predominant bilat-
eral epileptic activity; about half of children with hemiplegia had focal findings. In a
study of children with CP and epilepsy, only 7.9% of children had normal interictal
EEGs [Table 4] [4].
There was a correlation between brain CT scan and EEG findings; children with
bilateral brain abnormalities on their CT scan imaging often had bilateral and
generalized epileptiform abnormalities on their EEGs. However, one-fourth of
these children had a focal epileptiform abnormality with rapid bilateral synchrony.
On the other hand, 35.3% of children with unilateral structural brain abnormalities
on their CT scans had focal epileptiform abnormalities in their EEG recordings; the
EEG findings were concordant with the CT scan findings in all patients [11].
10.5 Neuroimaging in cerebral palsy with epilepsy
Children with CP and epilepsy appear to have abnormal brain imaging more
often. It is not surprising that a trend toward the occurrence of epilepsy was found
in children with gray matter insult (primarily cerebral infarcts), rather than in
children with white matter lesions. In addition, cerebral atrophy was also reported
more frequently in CP complicated by epilepsy [31], reaching statistical significance
in the study of Gururaj et al. [40]. A possible explanation for the association of
Table 4.
EEG abnormality and type of CP.
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atrophy and epilepsy is the fact that in many cases atrophy presents the end result
of prenatal or perinatal global ischemia with extensive neuronal damage.
Intraventricular hemorrhage was identified as a significant risk factor for the
development of neonatal seizures [41]. In patients with neonatal seizures, cerebral
dysgenesis and intraventricular hemorrhage proved to be predictors for poor out-
come [29].
Brain imaging in children with CP and epilepsy shows frequently abnormal
findings. In children with CP and epilepsy, cerebral atrophy is more often reported
[31, 40]. Atrophy is the consequence of prenatal and perinatal ischemia; this will
lead to an extensive neuronal damage which may be the cause of the seizures. A
significant risk factor for the development of neonatal seizures was found with
intraventricular hemorrhage [41]. Cerebral dysgenesis and intraventricular hemor-
rhage were found to be predictors of poor outcome in patients with neonatal
seizures [29].
The effect of imaging abnormalities in CP remains controversial. In one study,
an MRI abnormality was noted in 86.7% of patients, and the abnormal finding
variable in the MRI did not significantly affect the epilepsy development and sei-
zure outcome.
In other studies the range of abnormal findings in MRI was reported as 84–
88% [42]. Cerebral infarct is found by neuroimaging to be an abnormality that
significantly affects seizure outcome in epileptic patients with CP [4]. Table 5
shows the imaging findings in patients with CP and epilepsy and CP without
epilepsy.
Table 5.
Imaging findings in patients with cerebral palsy only and with cerebral palsy and epilepsy.
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10.6 Seizure control
More than 50% of seizures in patients with CP are fairly controlled. Seizures in
patients with hemiplegic CP achieve better control (75%) than those with quadri-
plegic and diplegic CP (50%); one study reported seizure control in children with
CP in nearly two-thirds [4]. Seizure control was achieved with monotherapy in the
majority of cases. Polytherapy was required in half, one-third, and one-fourth of
cases with diplegic, quadriplegic, and hemiplegic CP, respectively, although this
difference did not reach statistical significance. In another study by Hadjipanayis
et al., children with spastic hemiplegia (35%) and tetraplegia (28%) were more
likely to require polytherapy compared to patients with spastic diplegia (11%) [3];
however, the differences were not statistically significant [3]. Not surprising,
polytherapy was required more often in children with infantile spasms and myo-
clonic seizures. All other seizure characteristics also were more severe in the group
requiring polytherapy. In addition, a trend was noted for the following: seizures
began earlier, and CT and EEG abnormalities were more often present in children
requiring polytherapy.
10.7 Cerebral palsy: recommendation and future directions
The rate of CP has remained static for decades, at between 2 and 2.5 cases for
every 1000 live births, due to abnormalities of the developing fetal or infantile brain
resulting from a variety of causes. In a recent publication, however, Hollung et al.
reported that the prevalence of CP declined for children born in Norway from 2.62
per 1000 in 1999 to 1.89 in 2010, and in addition a substantial improvement in the
severity of clinical characteristics with a decrease in the proportion of children with
severe motor impairments, epilepsy, intellectual disability, and difficult to under-
stand or no speech was observed. They attributed this improvement to the better
obstetric and neonatal care the first decade of the twenty-first century [43]. In
general, however, methods that have been implemented, such as continuous elec-
tronic monitoring of the fetus in labor, have not had the anticipated benefits. Many
neuroprotective strategies have failed. In premature infants, an increase in survival
without a decrease in prevalence added more healthy citizens but also more dis-
abled children to the population. As a consequence in recent years, efforts have
focused on prevention, cure, early diagnosis, and early intervention in an attempt to
reduce further CP prevalence.
Approximately one-half of all new cases of cerebral palsy arise from the group of
neonates born prematurely (< 30 weeks gestation) that are at risk for long-term
neurodevelopmental problems, with almost one-half having motor, cognitive, and/
or language impairments, a rate much higher than their term peers [44]. For many
children, however, the cause of cerebral palsy is unclear. There are many known
risk factors that affect the fetal and neonatal developing brain leading to cerebral
palsy, and some of them can be prevented. Risk factors for congenital CP include
infection during pregnancy (toxoplasmosis, rubella, cytomegalovirus, and herpes
can infect the womb and placenta, leading to brain damage in the fetus), abuses of
alcohol or drugs during pregnancy, smoking, exposure to toxic chemicals, multiple
gestations, and infertility treatments that have an increased risk in preterm delivery
and multiple gestations and certain medical conditions such as diabetes, high blood
pressure, abnormal thyroid function, sexually transmitted infections, and eating
disorders (anorexia nervosa, bulimia nervosa, binge eating disorder). Placental
infarctions are most likely to be identified in the births of infants who will in the
13
Epilepsy and Cerebral Palsy
DOI: http://dx.doi.org/10.5772/intechopen.82804
future develop cerebral palsy, especially those with spastic quadriplegia, an early
reliable biomarker.
Before pregnancy we have to make sure that the woman is protected against
certain diseases such as rubella with vaccination and certain preventable infections
or cytomegalovirus (CMV). CMV in particular, is transmitted through close person-
to-person contact with infected secretions such as in urine and saliva. The infection
is transmitted from the mother to the fetus during pregnancy and can sometimes
cause stillbirth, premature birth, and neurological conditions such as cerebral palsy.
Children with cerebral palsy infected with CMV are more likely to have spastic
quadriplegia, severe functional mobility limitations and a range of associated
impairments including epilepsy, deafness, vision impairment, and moderate-to-
severe intellectual disabilities, than children born with cerebral palsy but without
CMV. There is evidence that public health approaches based on hygiene can dra-
matically reduce the rate of primary maternal cytomegalovirus infections during
pregnancy. Formulated consensus recommendations on the diagnosis, prevention,
and treatment of maternal and congenital CMV infection are found in the publica-
tion of Rawlinson et al. [45].
Our primary aim, therefore, is to provide a healthy pregnancy by advising and
treating appropriately treatable conditions and introduce current preventable strat-
egies and interventions that hold promise for reducing the prevalence of cerebral
palsy. Such interventions include strategies to decrease the risk of premature birth
(e.g., 17α-progesterone), limit the number of multiple gestations related to assisted
reproductive technology, treat mothers who are expected to deliver prior to
30 weeks gestation with magnesium sulfate for fetal neuroprotection that can pre-
vent cerebral palsy, give antenatal steroids for mothers expected to deliver prema-
turely, caffeine for extremely low-birth-weight neonates, and induce hypothermia
for a subgroup of neonates diagnosed with intrapartum hypoxic-ischemic encepha-
lopathy [46]. Hypothermia, either selectively applied to the head or total body,
appears to decrease the risk of cerebral palsy [47]. Interventions which either
prolong gestation or decrease the risk of preterm delivery will also decrease the risk
of cerebral palsy.
Although 50% of very preterm children has neurodevelopmental impairments,
an early prediction of infants who will experience problems later in life still remains
an early diagnostic challenge. White matter abnormalities (WMA) at term have
been associated with CP in very preterm children and can be used as a biomarker
for early multidisciplinary approach. Very preterm children with any WMA at term
require follow-up throughout childhood [48]. Abnormal general movements in
very preterm infants born <30 weeks gestation, particularly at 3 months post term,
are predictive of worse neurodevelopment at ages 2 and 4 years and need multidis-
ciplinary approach. The accuracy for predicting moderate to severe cognitive
impairment was good at 83% and 77% for 2 and 4 years, respectively [49].
Recent research on neuroplasticity supports intensive, repetitive, task-specific
intervention for CP that should commence early while the brain is most plastic.
Early postnatal recognition is important for a prompt referral to diagnostic-specific
early intervention setting to optimize infant’s motor and cognitive plasticity, pre-
vent secondary complications, and enhance caregiver’s well-being [50].
Beside traditional conventional therapies, physical therapy, occupational ther-
apy, and speech-language therapy, a number of other approaches have been used
such as the use of Botox, selective dorsal rhizotomy, functional vision assessment
and intervention programs, developmental optometry, biofeedback, hippotherapy,
hyperbaric oxygen therapy, deep brain stimulation for dyskinetic forms of cerebral
palsy, stem cell applications, and even yoga. It is very difficult to decide which
method is “gold standard” type of therapy for CP because it is impossible to conduct
14
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double-blind, randomized control trials. However, identifying predictive bio-
markers and developing preventive strategies phenotypically orientated to different
subsyndromes, we can prevent or intervene early taking into consideration the
advantage of brain plasticity.
11. Conclusions
In general children with CP have epileptic seizures in about one-third that occur
as a rule within the first 2 years of life. The most common seizure type is focal
generalized seizures followed by focal, infantile spasms, and myoclonic seizures
that are seen in one-fourth of cases. Seizures are most often seen in spastic hemi-
plegia and spastic quadriplegia. Children with CP and mental retardation have an
early onset of seizures and more severe epilepsy. The response to antiseizure treat-
ment in children with CP is generally difficult, and one-third to half of the cases is
receiving polytherapy and/or alternative therapies.
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